| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |